Evolent Health Inc Cl A Com (EVH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 190,007 | 179,451 | 202,692 | 181,813 | 267,447 |
| Receivables | 345,276 | 262,764 | 254,684 | 187,633 | 118,525 |
| TOTAL | $576,699 | $475,972 | $478,054 | $393,774 | $423,145 |
| Non-Current Assets | |||||
| PPE Net | 83,524 | 88,606 | 87,874 | 94,645 | 92,627 |
| Investments And Advances | 21,846 | 16,631 | 16,941 | 18,227 | 16,817 |
| Intangibles | 1,919,479 | 1,943,802 | 1,165,558 | 1,174,188 | 691,074 |
| Other Non-Current Assets | 45,283 | 64,448 | 68,866 | 78,348 | 80,249 |
| TOTAL | $2,070,132 | $2,113,487 | $1,339,239 | $1,365,408 | $880,767 |
| Total Assets | $2,646,831 | $2,589,459 | $1,817,293 | $1,759,182 | $1,303,912 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 76,953 | 51,012 | 57,174 | 61,863 | 96,565 |
| Accrued Expenses | 166,676 | 170,236 | 111,198 | 132,238 | 75,846 |
| Other current liabilities | 245,811 | 197,197 | 199,730 | 135,698 | 125,960 |
| TOTAL | $540,898 | $457,649 | $433,442 | $382,022 | $342,842 |
| Non-Current Liabilities | |||||
| Long Term Debt | 633,013 | 632,277 | 412,986 | 412,444 | 283,138 |
| Deferred Revenues | 6,950 | 7,069 | 5,758 | 7,524 | 8,711 |
| Other Non-Current Liabilities | 172,983 | 170,881 | 106,704 | 104,970 | 63,200 |
| TOTAL | $839,885 | $839,442 | $524,434 | $521,022 | $347,982 |
| Total Liabilities | $1,380,783 | $1,297,091 | $957,876 | $903,044 | $690,824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,245 | 112,668 | 111,052 | 101,191 | 91,670 |
| Common Shares | 1,131 | 1,125 | 1,015 | 1,012 | 916 |
| Retained earnings | -660,459 | -626,136 | -606,154 | -594,805 | -596,928 |
| Other shareholders' equity | -1,237 | -1,245 | -1,301 | -1,167 | -905 |
| TOTAL | $1,266,048 | $1,292,368 | $859,417 | $856,138 | $613,088 |
| Total Liabilities And Equity | $2,646,831 | $2,589,459 | $1,817,293 | $1,759,182 | $1,303,912 |